HIGHLIGHTS
- who: Jing Zhang and collaborators from the Fudan University, China have published the article: Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles, in the Journal: (JOURNAL) of March/20,/2022
- what: Jennifer et_al also showed that there was no significant This is a two-center, retrospective study, and the purpose of this study was to investigate the safety and efficacy of single and multiple applications of HIPEC for patients with T4 gastric cancer and to evaluate their impact on peritoneal metastasis. The study shows that both single . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.